Platelet activation in unstable coronary disease.
暂无分享,去创建一个
L Roy | G. FitzGerald | D. Fitzgerald | D J Fitzgerald | G A FitzGerald | L. Roy | F Catella | F. Catella
[1] L Morgenstern,et al. Coronary angioscopy in patients with unstable angina pectoris. , 1986, The New England journal of medicine.
[2] G. FitzGerald,et al. 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[3] P. Henriksson,et al. In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction. , 1986, British heart journal.
[4] G. FitzGerald,et al. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. , 1986, Circulation.
[5] G. FitzGerald,et al. Long-lived enzymatic metabolites of thromboxane B2 in the human circulation. , 1986, Analytical biochemistry.
[6] M. Weisfeldt,et al. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. , 1986, The New England journal of medicine.
[7] G. FitzGerald,et al. Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. , 1986, British medical journal.
[8] M. Kumlin,et al. Circulating and urinary thromboxane B2 metabolites in the rabbit: 11-dehydro-thromboxane B2 as parameter of thromboxane production. , 1986, Prostaglandins.
[9] M. Davies,et al. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. , 1986, Circulation.
[10] G. FitzGerald,et al. Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo. , 1986, The Journal of clinical investigation.
[11] G. FitzGerald,et al. Estimated rate of thromboxane secretion into the circulation of normal humans. , 1986, The Journal of clinical investigation.
[12] G. FitzGerald,et al. The biochemical pharmacology of thromboxane synthase inhibition in man. , 1985, Circulation.
[13] R. A. Coleman,et al. AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2. , 1985, Circulation.
[14] D. Sackett,et al. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. , 1985, The New England journal of medicine.
[15] G. FitzGerald,et al. Measurement of urinary 2,3-dinor-thromboxane B2 and thromboxane B2 using bonded-phase phenylboronic acid columns and capillary gas chromatography--negative-ion chemical ionization mass spectrometry. , 1985, Analytical biochemistry.
[16] E. Falk. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. , 1985, Circulation.
[17] R. Abbate,et al. Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina. , 1985, American heart journal.
[18] G. FitzGerald,et al. Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man. , 1985, Circulation.
[19] B. Weksler,et al. Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis. , 1985, Circulation.
[20] J. Knudsen,et al. Effect of specific thromboxane-synthetase inhibition on thromboxane and prostaglandin synthesis in stable angina induced by exercise test. , 1985, Thrombosis research.
[21] L. Fleisher,et al. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation. , 1984, Circulation.
[22] F. Crea,et al. Evaluation of the effects of catheter sampling for the study of platelet behavior in the pulmonary and coronary circulation. , 1984, American heart journal.
[23] E. Myhre,et al. Effects of a selective thromboxane synthetase inhibitor, dazoxiben, and of acetylsalicylic acid on myocardial ischemia in patients with coronary artery disease. , 1984, The American journal of cardiology.
[24] A. K. Pedersen,et al. Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. , 1984, The New England journal of medicine.
[25] R. M. Black. Book ReviewTextbook of Nephrology , 1984 .
[26] M. LeWinter,et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. , 1983, The New England journal of medicine.
[27] N. Wolf,et al. Intracoronary thrombus in nontransmural myocardial infarction and in unstable angina pectoris. , 1983, The American journal of cardiology.
[28] G. FitzGerald,et al. Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. , 1983, Circulation.
[29] G. FitzGerald,et al. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. , 1983, The Journal of clinical investigation.
[30] I. Hutton,et al. Effects of dazoxiben on transcardiac thromboxane levels and haemodynamics in coronary heart disease. , 1983, British Journal of Clinical Pharmacology.
[31] H. Gold,et al. Intracoronary thrombolysis in syndromes of unstable ischemia: angiographic and clinical results. , 1982, American heart journal.
[32] C. Patrono,et al. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. , 1982, The Journal of clinical investigation.
[33] C. Dollery,et al. Prostacyclin is not a circulating hormone in man. , 1982, Prostaglandins.
[34] J. Oates,et al. Estimated rate of prostacyclin secretion into the circulation of normal man. , 1981, The Journal of clinical investigation.
[35] G. FitzGerald,et al. Thromboxane A2 in Vasotonic Angina Pectoris , 1981 .
[36] L. Hillis,et al. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. , 1981, The New England journal of medicine.
[37] E. Salzman,et al. Circulating Platelet Products in Unstable Angina Pectoris , 1981, Circulation.
[38] K. Kaplan,et al. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo , 1981 .
[39] M S Golden,et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. , 1980, The New England journal of medicine.
[40] P. Walinsky,et al. Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal's angina. , 1979, Prostaglandins and medicine.
[41] J. Vane,et al. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. , 1976, Prostaglandins.
[42] S. Siegel,et al. Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.